The Announcement of Prices in Medicare Are Coming Soon, With Earnings Calls Offering a Glimpse into Negotiations

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv. We’re not done with smoothing

  Inflection Point The thorniest problem in biopharmaceuticals is the growing conflict between cost-effectiveness and budget impact. In other words, we increasingly have weapons against disease that are, objectively and

It’s been a slow week, so it’s probably useful for me to pause for a moment and think about what’s coming. Here’s a short list of the milestones that I’m